In this week's video, Dr. Brian Durie the new oral proteasome inhibitor ixazomib.

Bottom Line:
It will be very good for patients if ixazomib is as valuable as currently available drugs.

Previous Post
#AskDrDurie: Can you help make sense of statistics?
Next Post
What to expect from this year’s ASH: a preview

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.